Literature DB >> 2042054

Lyme disease: clinical manifestations, diagnosis, and treatment.

D W Rahn1.   

Abstract

Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States. The causative organism is transmitted through cutaneous inoculation by infected ixodid ticks. Illness typically begins in the summer with the characteristic skin rash, erythema migrans, and associated flulike symptoms. Weeks to months later, the majority of untreated individuals experience one or more manifestations of disseminated Lyme disease, primarily involving the nervous system, heart, and joints. Diagnosis is based on recognition of the appropriate signs and symptoms in the setting of travel to or residence in an endemic area, and supported by serological testing. All stages of the illness are responsive to antibiotics, although treatment is more efficacious when begun early in the course of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042054     DOI: 10.1016/0049-0172(91)90017-t

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  18 in total

Review 1.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Authors:  D Taylor-Robinson; A Keat
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 2.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

Review 3.  Lyme disease in the United Kingdom.

Authors:  S O'Connell
Journal:  BMJ       Date:  1995-02-04

4.  Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi.

Authors:  I Schwartz; S Bittker; S L Bowen; D Cooper; C Pavia; G P Wormser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

Review 5.  Systematic review of the treatment of early Lyme disease.

Authors:  P S Loewen; C A Marra; F Marra
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

Review 6.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis.

Authors:  D Liveris; A Gazumyan; I Schwartz
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  J J Schwartz; A Gazumyan; I Schwartz
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

9.  Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.

Authors:  K D Moody; R L Adams; S W Barthold
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

10.  Activation of gamma delta T cells by Borrelia burgdorferi is indirect via a TLR- and caspase-dependent pathway.

Authors:  Cheryl Collins; Cuixia Shi; Jennifer Q Russell; Karen A Fortner; Ralph C Budd
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.